Target intelligence / Profile preview

Caskin-1 (CASKIN1)

Target
CASKIN1
Molecular classification
Other (neuronal scaffolding protein), Adaptor/scaffolding protein
01

Overview

Caskin-1 (CASKIN1) is a large multidomain neuronal scaffolding and adaptor protein, predominantly expressed in brain tissue at both presynaptic and postsynaptic sites. It contains an N-terminal ankyrin repeat region, an atypical SH3 domain, two central tandem sterile-alpha motif (SAM) domains, and a C-terminal proline-rich region. Caskin-1 is notable for its interaction with the multidomain scaffolding protein CASK, via a short, conserved peptide motif, enabling the assembly of tripartite synaptic complexes essential for synaptic adhesion and neurotransmitter release. Its SAM domains can self-assemble into helical polymers, contributing to the organization and clustering of synaptic proteins at active zones. Besides CASK, Caskin-1 interacts with proteins such as neurexins, LAR family receptor protein tyrosine phosphatases, Dock, synaptotagmin, and others, suggesting a role in synaptic structure, function, and plasticity. Altered expression of Caskin-1 has been associated experimentally with neurodevelopmental and possibly epileptic phenotypes, although it is not currently a direct therapeutic target or known to have drug interactions[1][2][3].

Other names
CASK interacting protein 1KIAA1306ANKS5Acaskin-1CASKIN1
02

Biological functions

Signal transductionSynaptic organizationPresynaptic and postsynaptic scaffoldingModulation of neurotransmitter release
03

Disease associations

Neurodevelopmental disordersPotential role in epilepsyPossible link to neuropsychiatric disorders

Beyond the preview

Go deeper on Caskin-1 (CASKIN1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Caskin-1 (CASKIN1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call